CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-02 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −3,037 | 51,633 | ||
| 2021-11-01 | McAnear Justin J. Chief Financial Officer | Exercise or conversion | +10,000 | $5.04 | $50K | 49,100 |
| 2021-11-01 | McAnear Justin J. Chief Financial Officer | Sale | −300 | $160.48 | $48K | 48,800 |
| 2021-11-01 | McAnear Justin J. Chief Financial Officer | Sale | −500 | $162.16 | $81K | 48,300 |
| 2021-11-01 | McAnear Justin J. Chief Financial Officer | Sale | −4,667 | $163.34 | $762K | 43,633 |
| 2021-11-01 | McAnear Justin J. Chief Financial Officer | Sale | −4,333 | $164.05 | $711K | 39,300 |
| 2021-11-01 | McAnear Justin J. Chief Financial Officer | Sale | −200 | $164.96 | $33K | 39,100 |
| 2021-11-01 | McAnear Justin J. Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −10,000 | 370,159 | ||
| 2021-11-01 | STUELPNAGEL JOHN R Director | Sale | −100 | $160.33 | $16K | 361,516 |
| 2021-11-01 | STUELPNAGEL JOHN R Director | Sale | −100 | $160.75 | $16K | 361,416 |
| 2021-11-01 | STUELPNAGEL JOHN R Director | Sale | −100 | $161.52 | $16K | 361,316 |
| 2021-11-01 | STUELPNAGEL JOHN R Director | Sale | −1,494 | $163.10 | $244K | 359,822 |
| 2021-11-01 | STUELPNAGEL JOHN R Director | Sale | −2,906 | $163.89 | $476K | 356,916 |
| 2021-11-01 | STUELPNAGEL JOHN R Director | Sale | −300 | $164.58 | $49K | 356,616 |
| 2021-11-01 | Hindson Benjamin J. | Exercise or conversion | +10,232 | $5.04 | $52K | 57,349 |
| 2021-11-01 | Hindson Benjamin J. | Exercise or conversion | +31,434 | $11.48 | $361K | 88,783 |
| 2021-11-01 | Hindson Benjamin J. | Sale | −1,100 | $160.50 | $177K | 87,683 |
| 2021-11-01 | Hindson Benjamin J. | Sale | −1,500 | $162.06 | $243K | 86,183 |
| 2021-11-01 | Hindson Benjamin J. | Sale | −11,829 | $163.15 | $1.9M | 74,354 |
| 2021-11-01 | Hindson Benjamin J. | Sale | −24,125 | $163.87 | $4.0M | 50,229 |
Page 22 of 23 · 456 trades